Trial
NCT03374709
Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
Trigeminal Neuralgia
Intervention
Oxtellar XR 150Mg Extended Release Tablet
Why stopped
Resource and time constraints were encountered by product manufacturer and study team.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-01